Get started
RocketTickers

Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (bli

Long
Amgen Inc. (NASDAQ:AMGN)  
RocketTickers  
NASDAQ:AMGN   Amgen Inc.
Beyond Technical Analysis
8
0
beyondta
AMGN: Amgen
2019-09-24 16:00:00
Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.